Kaire Holdings Inc. Overview
(Updated 08/16/98)
Ticker Symbol: KAHI (OTC:Bulletin Board)
(Formerly Interactive Medical Technologies Ltd, OTC:NONI)
Founded: 1986
Company Information
Kaire Holdings Inc.
2139 Pontius Avenue
Los Angeles, CA 90025
U.S.A.
IR Contact: Bruce Barren
Tel: (310) 312-9652
Fax: (310) 473-5442
President: Peter Benz
Tel: (310) 312-9652
Tel: (415) 340-1074
Chairman and CEO: Steven Westlund
JD, CPA, CFO, Corporate Secretary & Director: Owen Naccarato
Transfer Agent: Jersey Transfer at (973) 239-2712
Email Address: imt@imt-ltd.com
Website: imt-ltd.com
Sec Filings: sec.gov
Yahoo Quote: quote.yahoo.com
Chart: chart4.bigcharts.com
Description:
Originally formed in 1986, as a biomedical company engaged in the study and development of regional blood flow products, today Interactive Medical Technologies, Ltd., ("IMT") is a diversified group of companies that collectively provide a range of products and services from non-radioactive medical contrast imaging media with laboratory services to medical researchers studying the effects of pharmaceutical drugs in human blood flow, to food supplements, anti-oxidants, vitamins, weight management and personal care products to the receptive growing world wide baby boomer market.
Based in Los Angeles, the IMT laboratory group manufactures and distributes non-radioactive contrast imaging media and provides related quantitative laboratory analysis developed from IMT patented technologies to leading pharmaceutical companies, academic centers, hospitals as well as private and government funded research facilities engaged in human blood flow studies.
At the foundation of the IMT consumer group is the recently acquired subsidiary, KAIRE International, Inc. Founded in 1992, based in Longmont, Colorado, KAIRE has grown to become a leading direct sales company marketing a unique diversified mix of food supplements, anti-oxidants, vitamins, weight management and personal care products through its growing force of 85,000 core distributors throughout North America, Australia, New Zealand, Trinidad, Korea and the United Kingdom.
Recent News Releases:
imt-ltd.com
imt-ltd.com
imt-ltd.com
Other Information:
imt-ltd.com
imt-ltd.com
Silicon Investor Thread:
Subject 20168
StockWiz Email:
Message 5493222
Shareholder and Financial Information:
Shares outstanding: 16,000,000 (approx.)
Float: 13,000,000 (approx.)
Reverse Split: 75-1 (02/19/1998)
Estimated Revenue: FY97 $3 million
FY98 $25-50 million
Uunaudited consolidated revenue for Jan, Feb FY98 is $5 million.
Pre-tax profit margin: 10% (industry average 9-12%)
Estimated Pre-Tax Earnings: FY98 is $2.5-5.0 million
Estimated Pre-Tax EPS: FY98 $.60 - $1.20
Forcasted 98 Income including N.America, Australia, New Zealand,Trinidad, Korea, and Europe, exclusive of China is $2.5 million
Cash: The company expects to continuously have sufficient cash to meet it's obligations. No issuance of stock to raise operating capital is expected.
Major Acquisitions:
12/9/97 Kaire Internantional - Stock issued to Kaire Holders = 23% of current outstanding shares.
3/6/98 Newel Resource Trading Pte. Ltd (35% stake) (Nanjing Potomac Beauty and Health Care) - Stock issued to Newel = 25% then outstanding shares (848,764 shares)
The most recent SEC 10Q is 11/17/97 and covers 3Q97, which is prior to the acquisition of Kaire International. This acquisition made substantially change the financial base of the company. Current financials are being audited, with release expected in September. This audit is being conducted in preparation of NASDAQ listing. A formal S-3 will be filed on the Potomak acquisition when the audit is completed.
******************************************************************************
KAHI owns 35% Potomak
Kaire acquired a stake in the Nanjing Potomak Beauty and Health Care Co., LTd which has existing sales licences in China, Thailand, Philippines, Taiwan, and Malaysia. The principles of Potomak have visited Kaire and selected two Kaire products to introduce to the Chinese market. Potomak has in excess of 300,000 distributors in Mainland China. Chinese import licences for the two products have been applied for. The products in question are natural and expected to be approved without difficulty. Chinese import licences usually take 6-12 months to be granted.
Potomak Snapshot: Potomak is one of 40 direct sales companies licensed by the Mainland Chinese government. They have 700 employees and licenses to operate in 30 different cities. FY97 sales: 100 million RMB FY98 sales 150 million RMB ($10 and $15 million US$?) Potomak has a 9,000 square meter factory in the Nanjing Jiangpu Industrial Zone. ISO9000 approval expected May 1998. The factory has the capacity to produce 500 tons of household chemicals and cosmetics, 50 tons of health foods, and 20,000 sets of shape forming underwear. Potomak is vertically integrated in that they both produce and directly distribute product.
Net Income 97 (unaudited) 415,245 $US
Industry Description:
Network marketing is a $20 billion industry. Industry growth has been 20-30% annually. Nutritional supplements generate $13 billion of this total.
Industry average PE is 15-30. This is usually 1.2-2.8 annual revenue. Similar companies: NATR,USNA,HERB,AMRI,AAP,ASX,AMW
******************************************************************************
KAHI owns 23% of Kaire International, Inc.
380 Lashley St.
Longmont, CO 80501
Phone: 303-682-0110
Fax: 303-682-9094
Web Site: kaireint.com
IPO INFORMATION
Filing date: February 11, 1998
Expected IPO date: TBA
Exchange: Nasdaq (SC)
Proposed offer price: $6.00
Shares offered (mil.): 1.0
Post-offering shares(mil.): 5.418
Offering amount (mil.): $6.0
Underwriters: May Davis Group, Inc.
Kaire International develops and distributes health care supplements and personal care products through its network of independent representatives in Australia, Canada, New Zealand, and the US. Its line of about 50 products include its best-seller, the Maritime Prime antioxidant, and others designed for weight loss, antiaging, and stress reduction. Kaire buys its products from manufacturers and sells them to its 60,000 active salespeople, who, in addition to their retail profits, get commissions for recruiting new sellers. After the planned IPO, Interactive Medical Technologies will reduce its share of the company from 81% to 66%.
Key People
CEO: Robert L. Richards
CFO: J. T. Whitworth
Key Numbers
Fiscal Year-End: December
1997 Sales (mil.): $35.7
1-Yr. Sales Change: (30.7%)
1997 Income (mil.): $(5.7)
Employees: 75
News:
"Master Your Destiny"
1998 Convention News
KAIRE INTERNATIONAL IS PLEASED to announce an important international event
scheduled for September 17, 18, and 19 in Dallas, Texas. Kaire invites each of you to join us at
the beautiful Hotel Inter-Continental in Dallas for our 1998 convention. You will have the
opportunity to hear from leading experts in the field of health and nutrition, successful Kaire
Associates who will teach you how to "Master Your Destiny", and world renowned motivational
speakers. You will learn about new revolutionary products exclusive to Kaire International, have
fun, be entertained, educated and recognized. We encourage all Associates to participate in this exciting corporate event. Join your fellow Associates from around the world as we celebrate the accomplishments of the past year and look forward to the successes of the future. Mark your calendars and make your arrangements to attend for the experience of a lifetime. Associates may call Kaire Travel Services at 1-800-397-8646 for additional information. More information will be forthcoming with your product orders, bonus checks and facsimile broadcasts.
See you in September!!
******************************************************************************
All of the above was gleaned from press releases, the KAHI web site, the KAHI thread on Silicon Investor, or from other stockholders E-mail and phone calls to KAHI.
This information has been compiled by me, an independent investor, and is presented to be as accurate as possible according to the information that I have been able to obtain from public sources. This should NOT be assumed exact, but is presented as a starting point for research purposes. |
